Daiwa Securities Group’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,641
| Closed | -$400K | – | 1305 |
|
|
2025
Q1 | $400K | Hold |
1,641
| – | – | ﹤0.01% | 869 |
|
|
2024
Q4 | $539K | Hold |
1,641
| – | – | ﹤0.01% | 818 |
|
|
2024
Q3 | $549K | Sell |
1,641
-620
| -27% | -$207K | ﹤0.01% | 816 |
|
|
2024
Q2 | $618K | Buy |
2,261
+31
| +1% | +$8.47K | ﹤0.01% | 791 |
|
|
2024
Q1 | $771K | Buy |
2,230
+328
| +17% | +$113K | ﹤0.01% | 768 |
|
|
2023
Q4 | $614K | Buy |
1,902
+68
| +4% | +$22K | ﹤0.01% | 786 |
|
|
2023
Q3 | $657K | Buy |
1,834
+157
| +9% | +$56.2K | ﹤0.01% | 776 |
|
|
2023
Q2 | $636K | Sell |
1,677
-49
| -3% | -$18.6K | ﹤0.01% | 770 |
|
|
2023
Q1 | $827K | Buy |
1,726
+132
| +8% | +$63.2K | 0.01% | 698 |
|
|
2022
Q4 | $670K | Buy |
1,594
+28
| +2% | +$11.8K | 0.01% | 741 |
|
|
2022
Q3 | $653K | Buy |
1,566
+18
| +1% | +$7.51K | 0.01% | 739 |
|
|
2022
Q2 | $766K | Buy |
1,548
+5
| +0.3% | +$2.47K | 0.01% | 723 |
|
|
2022
Q1 | $869K | Buy |
1,543
+40
| +3% | +$22.5K | 0.01% | 735 |
|
|
2021
Q4 | $1.14M | Sell |
1,503
-17
| -1% | -$12.8K | 0.01% | 671 |
|
|
2021
Q3 | $1.13M | Buy |
1,520
+130
| +9% | +$97K | 0.01% | 644 |
|
|
2021
Q2 | $896K | Buy |
1,390
+73
| +6% | +$47.1K | 0.01% | 688 |
|
|
2021
Q1 | $752K | Buy |
1,317
+38
| +3% | +$21.7K | 0.01% | 707 |
|
|
2020
Q4 | $746K | Buy |
1,279
+8
| +0.6% | +$4.67K | 0.01% | 653 |
|
|
2020
Q3 | $655K | Buy |
1,271
+116
| +10% | +$59.8K | 0.01% | 616 |
|
|
2020
Q2 | $405K | Hold |
1,155
| – | – | 0.01% | 603 |
|
|
2020
Q1 | $405K | Buy |
1,155
+65
| +6% | +$22.8K | ﹤0.01% | 701 |
|
|
2019
Q4 | $403K | Buy |
+1,090
| New | +$403K | ﹤0.01% | 764 |
|